One of the greatest challenges facing the pharmaceutical industry is the rapid spread of multi-resistant germs. Two Graz researchers have found a revolutionary approach to combating the germs without having to deal with constant derivatives of the germs. First animal experiments show very encouraging results and give hope that further studies on the path to approval of the drug will be successful. However, the financial expenses are enormous, so that adMONDO was commissioned to look for potential partners and investors in the pharmaceutical industry
Menu